(Q37820990)

23 August 2017

1 reference

title

Mood stabilizers for patients with bipolar disorder: the state of the art. (English)

1 reference

23 August 2017

0 references

1 reference

Bernardo Dell'Osso

6

0 references

author name string

A Carlo Altamura

1

1 reference

23 August 2017

Licia Lietti

2

1 reference

23 August 2017

Cristina Dobrea

3

1 reference

23 August 2017

Beatrice Benatti

4

1 reference

23 August 2017

Chiara Arici

5

1 reference

23 August 2017

language of work or name

1 reference

1 January 2011

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

23 August 2017

published in

1 reference

23 August 2017

volume

11

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

85-99

1 reference

Is bipolar disorder overdiagnosed among patients with substance abuse?

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Comorbidity and bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

What is a "mood stabilizer"? An evidence-based response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Clinical relevance of drug interactions with lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Neural and developmental actions of lithium: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

A molecular mechanism for the effect of lithium on development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

A case of serotonin syndrome caused by venlafaxine and lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Serotonin syndrome induced by fluvoxamine-lithium interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

A review of valproate in psychiatric practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Antiepileptic drug pharmacokinetics and interactions: impact on treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Oxcarbazepine: clinical experience with hospitalized psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Safety and tolerability of lamotrigine for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Lamotrigine: a review of its use in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Olanzapine. Pharmacokinetic and pharmacodynamic profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Asenapine: a novel psychopharmacologic agent with a unique human receptor signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Long-term symptomatic status of bipolar I vs. bipolar II disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

The long-term natural history of the weekly symptomatic status of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.10.181

21 January 2018

Identifiers

DOI

10.1586/ERN.10.181

1 reference

23 August 2017

1 reference